| Jeffrey Yee, | |
|
3051 W Maple Loop Dr Ste 300, Lehi, UT 84043-6552 | |
| (385) 336-4740 | |
| Not Available |
| Full Name | Jeffrey Yee |
|---|---|
| Gender | Male |
| Speciality | Counselor - Mental Health |
| Location | 3051 W Maple Loop Dr Ste 300, Lehi, Utah |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1093106726 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 101YM0800X | Counselor - Mental Health | 9806460-6009 (Utah) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Jeffrey Yee, 3501 West Maple Loop Drive, Suite 300, Lehi, UT 84043 Ph: (385) 336-4740 | Jeffrey Yee, 3051 W Maple Loop Dr Ste 300, Lehi, UT 84043-6552 Ph: (385) 336-4740 |
News Archive
A new gene that causes early-onset of Alzheimer's disease has been discovered by the research team of Dominique Campion at the Insert unit 1079 "Genetics of cancer and neuropsychiatric diseases" in Rouen.
HIT Application Solutions, a leading healthcare technology development company, announced today the company has raised $2.75 M USD in its Series A funding effort.
Anti-microbial antibody formation has been reported in celiac disease. Relatively high positivity rates were observed for the conventional antibodies, for example, ASCA, anti-OmpW, and anti-I2, and they were known to decrease after a successful gluten free-diet. The importance of newly discovered inflammatory bowel disease-associated antibodies (including anti-glycan antibodies and anti-OMP) in celiac disease is not sure.
Since 1990, Creighton University School of Medicine professor and researcher Devendra K. Agrawal, Ph.D., has been awarded more than $20 million in research grants to study coronary artery heart disease. He is determined to eradicate the impact of this heart disease—the number one killer of men and women in the United States.
Halozyme Therapeutics, Inc. today announced the commencement of a Phase 1 clinical study that will assess the effects of three approved prandial (mealtime) insulin analogs administered with its proprietary rHuPH20 (PH20) hyaluronidase enzyme compared to each of the analogs alone. This randomized, three-way cross-over design, euglycemic clamp study will compare the postprandial pharmacokinetics (PK) and glucodynamics (GD) of the insulin analogs.
› Verified 2 days ago
Rosalie Dirado, Counselor Medicare: Not Enrolled in Medicare Practice Location: 50 N 200 E Ste A, Lehi, UT 84043 Phone: 801-766-3933 | |
Jeffrey Stewart, Counselor Medicare: Not Enrolled in Medicare Practice Location: 4735 N Thanksgiving Way, Lehi, UT 84043 Phone: 801-885-9595 | |
Whitney Evans, ACMHC Counselor Medicare: Not Enrolled in Medicare Practice Location: 3051 W Maple Loop Dr Ste 202, Lehi, UT 84043 Phone: 385-254-3522 | |
James Leblow, Counselor Medicare: Not Enrolled in Medicare Practice Location: 4735 North Thanksgiving Way, Lehi, UT 84043 Phone: 013-106-8808 | |
Norma Farris, Counselor Medicare: Not Enrolled in Medicare Practice Location: 3051 W Maple Loop Dr Ste 210, Lehi, UT 84043 Phone: 801-872-5516 Fax: 801-880-0069 | |
Eden Clegg, Counselor Medicare: Not Enrolled in Medicare Practice Location: 4735 N Thanksgiving Way, Lehi, UT 84043 Phone: 801-310-6880 |